Rend Al-Mondhiry Quoted in “Immune Health: Supplement Support Driven by Ingredient Innovation”
In a feature covering the $5.5 billion immune health market after Covid-19, Natural Products Insider posed the following question to Rend Al-Mondhiry —
“Structure/function claims and immunity messaging: What do science and the law tell us?”
Rend responded: “The line between disease claims and structure/function claims isn’t always easy to identify, but regulatory guidance is available to provide insights into permissible, substantiated immune health claims. Otherwise, brands face risks like a class action lawsuit; FDA warning letter; FTC inquiry or investigation; or a competitor challenge, such as through the National Advertising Division.”
Read the full story here.
